Triple blinded prospective study assessing the impact of genomics: EndoPredict and artificial intelligence Watson for Oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma.

S. P. Somashekhar,Ramya Yethadka,Rohit Kumar C,Ashwin K Rajgopal,Amit Rauthan,Poonam Patil

Triple blinded prospective study assessing the impact of genomics: EndoPredict and artificial intelligence Watson for Oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma.

2019

S. P. Somashekhar
Ramya Yethadka
Rohit Kumar C
Ashwin K Rajgopal
Amit Rauthan
Poonam Patil

e18013Background: : Decision on adjuvant systemic therapy in hormone positive early breast carcinoma is the only grey area in breast carcinoma management. This study was done to investigate the con...

Keywords:

Hormone receptor
Genomics
Carcinoma
Adjuvant
Prospective cohort study
Systemic therapy
Internal medicine
Medicine
Oncology
breast carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations